US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Renaissance Technologies Holdings

1,856.76

+19.321.05%

Number of Gainers:42

Number of Losers:54

Number of Flat:- -

PE:- -

High:1,868.62

Open:1,839.91

Low:1,833.85

Close:1,837.44

Loading ...

Incyte - Topline Data From Separate Phase 3 Study, True-Pn2, Showed That Primary Endpoint Did Not Reach Statistical Significance

THOMSON REUTERS

Incyte Corp - Phase 3 True-Pn1 Study Meets All Primary and Key Secondary Endpoints

THOMSON REUTERS

Incyte Announces Results of Phase 3 Clinical Trials Evaluating Ruxolitinib Cream 1.5% (Opzelura®) in Patients With Prurigo Nodularis (Pn) at 2025 American Academy of Dermatology Annual Meeting

THOMSON REUTERS

Bristol Myers Squibb Presents Late-Breaking Data From Phase 3 Poetyk Psa-2 Trial Demonstrating Superiority of Sotyktu (Deucravacitinib) Compared With Placebo in Adults With Psoriatic Arthritis

THOMSON REUTERS

Bristol-Myers Squibb Co - Sotyktu Well-Tolerated Compared to Placebo and Apremilast

THOMSON REUTERS

Incyte Announces Results of Phase 3 Clinical Trials Evaluating Ruxolitinib Cream 1.5% (Opzelura®) in Patients with Prurigo Nodularis (PN) at 2025 American Academy of Dermatology Annual Meeting

The Coca-Cola Company (KO): Jim Cramer Raves – ‘Coca-Cola Has Been Amazing. Amazing!’

Jim Cramer On Lowe’s Companies, Inc. (LOW): “Marvin Ellison’s Excellent Quarter – It’s Not as Bad as Feared”

25% of Warren Buffett-Led Berkshire Hathaway's $288 Billion Portfolio Is Invested in Only 1 Stock

Alphabet Inc. (GOOGL)’s Google Cloud Partners to Advance Global Geothermal Energy

Insider Trading Shakes Up Pacific Biosciences, Nutanix, Coupang, CSX, and Williams Co

Why The 49% Return On Capital At National Beverage (NASDAQ:FIZZ) Should Have Your Attention

Simply Wall St.

An Intel deal now seems less likely. These clues may hold the key to its future.

Is Barrick Gold Corporation (GOLD) the Best Cash-Rich Undervalued Stock to Invest In?

This Customer Trend Helped Save Walmart's Quarter, but Does It Spell Trouble for the Year Ahead?

Is Tenaris S.A. (TS) the Best Cash-Rich Undervalued Stock to Invest In?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4532/news?page=25"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4532"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4532\",,,,,undefined,":{"symbol":"BK4532","market":"US","secType":"PLATE","nameCN":"Renaissance Technologies Holdings","latestPrice":1856.7594,"timestamp":1741809599999,"preClose":1837.4403,"halted":0,"volume":1062587032,"delay":0,"changeRate":0.010514,"change":19.319092,"pbRate":8.294774,"amount":124956966627.03564,"amplitude":0.018924,"prevYearClose":2026.1482,"fiveDayClose":1940.7825,"twentyDayClose":2037.8518,"turnoverRate":0.008257,"marketCap":20703525198832,"floatMarketCap":19371528037056,"peRate":30.297462},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4532\",,,,,undefined,":{"symbol":"BK4532","high":1868.6184,"amplitude":0.018924,"preClose":1837.4403,"low":1833.8467,"pbRate":"8.294774","latestPrice":1856.7594,"volume":1062587032,"delay":0,"open":1839.9092,"prevYearClose":2026.1482,"prevWeekClose":1912.7213,"prevMonthClose":1965.7411,"prevQuarterClose":2026.1482,"fiveDayClose":1940.7825,"twentyDayClose":2037.8518,"sixtyDayClose":2102.1726,"secType":"PLATE","market":"US","turnoverRate":0.008257,"peRate":30.297462,"marketCap":20703525198832,"floatMarketCap":19371528037056,"timestamp":1741809599999,"nameCN":"Renaissance Technologies Holdings"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4532\",,,,undefined,":{"bkCode":"BK4532","up":42,"down":54,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4532\",pageSize:16,pageCount:25,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517441677","title":"Incyte - Topline Data From Separate Phase 3 Study, True-Pn2, Showed That Primary Endpoint Did Not Reach Statistical Significance","url":"https://stock-news.laohu8.com/highlight/detail?id=2517441677","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517441677?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:01","pubTimestamp":1741442460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250308:nTUA40P8T6:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4532","BK4585","BK4139","BK4550","INCY"],"gpt_icon":0},{"id":"2517441624","title":"Incyte Corp - Phase 3 True-Pn1 Study Meets All Primary and Key Secondary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2517441624","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517441624?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:01","pubTimestamp":1741442460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250308:nTUA40P8T6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4550","BK4588","BK4532","INCY","BK4585","BK4139"],"gpt_icon":0},{"id":"2517441510","title":"Incyte Announces Results of Phase 3 Clinical Trials Evaluating Ruxolitinib Cream 1.5% (Opzelura®) in Patients With Prurigo Nodularis (Pn) at 2025 American Academy of Dermatology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2517441510","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517441510?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:01","pubTimestamp":1741442460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250308:nTUA40P8T6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INCY","BK4550","BK4139","BK4585","BK4588","BK4532"],"gpt_icon":0},{"id":"2517744151","title":"Bristol Myers Squibb Presents Late-Breaking Data From Phase 3 Poetyk Psa-2 Trial Demonstrating Superiority of Sotyktu (Deucravacitinib) Compared With Placebo in Adults With Psoriatic Arthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2517744151","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517744151?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:01","pubTimestamp":1741442460,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250308:nTUA3WWKR9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","IE00BJJMRZ35.SGD","BK4585","LU2125154778.USD","IE00BFXG1179.USD","LU0321505439.SGD","LU1868837136.USD","LU1670710588.SGD","LU0882574055.USD","LU1032466523.USD","BK4559","LU0456855351.SGD","LU0868494617.USD","LU2242646821.SGD","LU1323610961.USD","IE00B2B36J28.USD","IE0002141913.USD","LU0985481810.HKD","LU2133065610.SGD","BK4534","BK4581","LU0061475181.USD","LU1261432733.SGD","LU0225771236.USD","LU1670711123.USD","LU1989771016.USD","LU1868836757.USD","LU0237698245.USD","BK4588","IE00BJT1NW94.SGD","LU2125154935.USD","BMY","LU1291159041.SGD","LU1670710661.SGD","LU1093756168.USD","LU0096364046.USD","LU1571399168.USD","LU1074936037.SGD","IE00BFTCPJ56.SGD","LU1868836591.USD","LU0321505868.SGD","LU1670711040.USD","BK4532","LU1430594728.SGD","LU0306807586.USD","LU1868837300.USD","IE0009355771.USD","LU1718418525.SGD","LU2242652126.USD","LU1585245621.USD"],"gpt_icon":0},{"id":"2517415264","title":"Bristol-Myers Squibb Co - Sotyktu Well-Tolerated Compared to Placebo and Apremilast","url":"https://stock-news.laohu8.com/highlight/detail?id=2517415264","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517415264?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:01","pubTimestamp":1741442460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250308:nTUA3WWKR9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0868494617.USD","LU0306806265.USD","LU0061475181.USD","IE0002141913.USD","LU2133065610.SGD","LU2360032135.SGD","BK4581","LU1291159041.SGD","LU1093756168.USD","LU1670711123.USD","LU0225771236.USD","IE00BJT1NW94.SGD","BK4585","LU1868836757.USD","LU0456855351.SGD","IE00BFTCPJ56.SGD","LU0096364046.USD","LU1868836914.USD","LU1868837300.USD","LU0882574055.USD","LU1093756325.SGD","IE0009355771.USD","LU1585245621.USD","LU1868837136.USD","LU2125154935.USD","BK4007","LU2125154778.USD","LU1323610961.USD","LU0114720955.EUR","IE00BFXG1179.USD","BMY","LU0225284248.USD","LU2242652126.USD","LU1670711040.USD","LU0321505868.SGD","BK4588","IE00BSNM7G36.USD","LU1718418525.SGD","BK4532","IE00B2B36J28.USD","LU1074936037.SGD","IE00BJJMRZ35.SGD","LU1571399168.USD","BK4559","LU1868836591.USD","LU0237698245.USD","LU1670710661.SGD","LU1032466523.USD","BK4534","LU1670710588.SGD"],"gpt_icon":0},{"id":"2517441685","title":"Incyte Announces Results of Phase 3 Clinical Trials Evaluating Ruxolitinib Cream 1.5% (Opzelura®) in Patients with Prurigo Nodularis (PN) at 2025 American Academy of Dermatology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2517441685","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517441685?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:01","pubTimestamp":1741442460,"startTime":"0","endTime":"0","summary":"- Full data from the Phase 3 TRuE-PN1 study, presented today in a late-breaking oral presentation, showed the study met all primary and key secondary endpoints. - Topline data from a separate Phase 3 study, TRuE-PN2, showed that while the primary endpoint did not reach statistical significance, the primary and all key secondary endpoints were in favor of ruxolitinib cream 1.5% versus vehicle. WILMINGTON, Del., March 08, 2025----Incyte  today announced results from its pivotal Phase 3 TRuE-PN clinical trial program –TRuE-PN1 and TRuE-PN2 studies – evaluating the safety and efficacy of twice-daily ruxolitinib cream 1.5% , a topical JAK1/2 inhibitor, in adult patients  with prurigo nodularis . The positive TRuE-PN1 data were presented as a late-breaking oral presentation  today at the 2025 American Academy of Dermatology  Annual Meeting, being held March 7–11, 2025, in Orlando.Additionally, topline data from the Phase 3 TRuE-PN2 clinical trial demonstrated a strong positive trend across a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/incyte-announces-results-phase-3-140100487.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PN","BK4588","INCY","BK4117","BK4585","BK4107","AFG","BK4139","BK4532","BK4550","BSA"],"gpt_icon":0},{"id":"2517449712","title":"The Coca-Cola Company (KO): Jim Cramer Raves – ‘Coca-Cola Has Been Amazing. Amazing!’","url":"https://stock-news.laohu8.com/highlight/detail?id=2517449712","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517449712?lang=en_us&edition=fundamental","pubTime":"2025-03-08 21:31","pubTimestamp":1741440660,"startTime":"0","endTime":"0","summary":"We recently published a list of Jim Cramer Discusses These 13 Stocks & Criticizes Billionaires. In this article, we are going to take a look at where he Coca-Cola Company  stands against other stocks that Jim Cramer discusses.In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer continued to warn users to not trust billionaires. His remarks built on an earlier show, where he had shared that “you can’t make money listening to a billionaire because they already have made money.”This time around, Cramer outlined that billionaires often share the sentiment that it’s hard for others to become as rich as they are. “They close the door,” he commented and added: “Well they’re always negative.” Cramer also believes that luck might play a large role in making someone a billionaire. According to him: “We never, we never grade them because if they’re billionaires we think that they have to be genius. We never think about luck. We just think, well they might have had really great trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/coca-cola-company-ko-jim-133100281.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1221951129.SGD","LU1732800096.USD","LU2237443549.SGD","LU1670711040.USD","BK4532","LU1894683264.USD","SG9999014575.USD","IE00BDGV0183.EUR","LU0957791311.USD","LU2237443382.USD","SG9999011175.SGD","SG9999015358.SGD","LU1815333072.USD","LU2237443895.HKD","SG9999002224.SGD","LU0912757837.SGD","BK4610","BK4585","IE00B42XCP33.USD","LU1116320737.USD","LU2125154778.USD","LU1221951046.USD","LU2108987350.USD","LU0323591593.USD","IE00BLSP4452.SGD","BK4504","SG9999014542.SGD","LU1162221912.USD","LU1670711123.USD","LU1116320901.HKD","IE00BVYPNW00.USD","LU2360032135.SGD","LU2133065610.SGD","LU1196500208.SGD","LU1868836591.USD","LU0950375773.USD","LU0795875086.SGD","LU0289960550.SGD","SG9999003800.SGD","LU2237443465.HKD","KO","LU0795875169.SGD","LU0175139822.USD","SG9999014567.USD","LU2125154935.USD","LU2264538146.SGD","LU1894683348.USD","BK4581","LU1718418525.SGD","LU0265550946.USD"],"gpt_icon":1},{"id":"2517415024","title":"Jim Cramer On Lowe’s Companies, Inc. (LOW): “Marvin Ellison’s Excellent Quarter – It’s Not as Bad as Feared”","url":"https://stock-news.laohu8.com/highlight/detail?id=2517415024","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517415024?lang=en_us&edition=fundamental","pubTime":"2025-03-08 21:30","pubTimestamp":1741440621,"startTime":"0","endTime":"0","summary":"We recently published a list of Jim Cramer Discusses These 14 Stocks & Zero Day Options. In this article, we are going to take a look at where Lowe’s Companies, Inc.  stands against other stocks that Jim Cramer discusses with insights into Zero Day Options.The CNBC TV show host also commented on how the GPU company needed to “get away from this five clients syndrome.” He believes that if the firm’s only clients are going to be mega-cap technology giants then “We’re all gonna just keep saying, are they ordering? Are they ordering? If you have an order book that includes say, many countries, uh that’d be great.”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jim-cramer-lowe-companies-inc-133021809.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0868494617.USD","LU2275660780.HKD","LU2237443978.SGD","BK4581","LU2237443622.USD","LU2237443895.HKD","BK4585","LU0198837287.USD","BK4083","BK4534","LU1074936037.SGD","BK4504","LU2237443549.SGD","BK4597","LU0312595415.SGD","BK4532","LU2237443382.USD","LU0868494708.USD","LU2237443465.HKD","IE0034235188.USD","BK4588","HD","LOW","LU0942090050.USD","LU0302445910.USD","BK4533"],"gpt_icon":0},{"id":"2517449514","title":"25% of Warren Buffett-Led Berkshire Hathaway's $288 Billion Portfolio Is Invested in Only 1 Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2517449514","media":"Motley Fool","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517449514?lang=en_us&edition=fundamental","pubTime":"2025-03-08 21:30","pubTimestamp":1741440600,"startTime":"0","endTime":"0","summary":"Perhaps Buffett’s most lucrative investment occurred in the last decade, with this company’s shares producing a total return of 900% since the start of 2016.A strong consumer brand, incredible financials, and a cheap valuation probably caught Buffett’s attention.Investors should consider this company’s growth prospects and valuation with a fresh perspective today.Since Buffett's track record speaks for itself, it makes sense why investors might immediately think his stock holdings are automatic buys for their own portfolios. However, in this instance, I believe investors should be a bit more critical and think independently. In fact, I don't think Apple is currently a smart buy.Consider its growth. In fiscal 2024 , revenue increased just 2%. That improved to 4% growth in Q1 2025. But it's worth mentioning that Apple's sales in the latest fiscal quarter were roughly the same as three years before.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/03/08/warren-buffett-berkshire-billion-portfolio-1-stock/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU2087621335.USD","BK4505","HK0000320264.USD","SG9999015952.SGD","LU0943347566.SGD","LU0466842654.USD","BK4559","SG9999014898.SGD","LU0097036916.USD","LU2242650005.HKD","LU1280957306.USD","LU0289961442.SGD","SG9999002232.USD","LU0251132253.USD","BK4573","LU0784383803.USD","LU2471134879.HKD","LU1291159041.SGD","LU2133065610.SGD","LU1496350171.SGD","SG9999018857.SGD","LU0345770993.USD","LU1066051811.HKD","LU2360106780.USD","MACW.SI","BRK.B","IE00B19Z9505.USD","BK4532","BK4501","LU0965509010.AUD","IE000W1ABFV2.USD","LU0949170772.SGD","LU0080751232.USD","LU0672654240.SGD","LU1506573853.SGD","IE0009G5SDU7.USD","LU2360032135.SGD","SG9999014575.USD","LU2092627202.USD","LU0170899867.USD","BRK.A","LU2552382132.HKD","SG9999014559.SGD","IE000KEQY171.SGD","LU1917777945.USD","IE00BFSS8Q28.SGD","LU2458330169.SGD","BK4592","LU0528227936.USD"],"gpt_icon":1},{"id":"2517497184","title":"Alphabet Inc. (GOOGL)’s Google Cloud Partners to Advance Global Geothermal Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2517497184","media":"Insider Monkey","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517497184?lang=en_us&edition=fundamental","pubTime":"2025-03-08 21:24","pubTimestamp":1741440284,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 AI Stocks That Wall Street Is Betting On.In this article, we are going to take a look at where Alphabet Inc.  stands against the other AI stocks.Elon Musk has been pressing hard to halt OpenAI’s transition into a for-profit entity. But the high-stakes legal battle isn’t seemingly working out in his favor. In the latest news, a U.S. judge has denied the billionaire's request for a preliminary injunction to pause OpenAI's transition to a for-profit model. However, she did agree to a fast-track trial in the fall of this year to address his claims against OpenAI and its CEO, Sam Altman.The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 per","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alphabet-inc-googl-google-cloud-132444566.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SLB","IE00BZ199S13.USD","LU0215105999.USD","LU1280957306.USD","ML","LU0122376428.USD","LU1691799644.USD","LU0980610538.SGD","LU0354030511.USD","LU2237443895.HKD","LU2362540622.SGD","USJW.SI","LU0251131958.USD","LU2403377893.USD","LU0345770308.USD","LU0476273544.USD","GOOGL","BK4527","LU1804176565.USD","LU0289941410.SGD","LU0861579265.USD","LU2458330243.SGD","LU0444973449.USD","LU0719512351.SGD","LU1043141396.HKD","LU1435385759.SGD","IE00BKPKM429.USD","GOOG","BK4602","BK4581","LU0203345920.USD","LU2023250330.USD","LU0417517546.SGD","IE00B1BXHZ80.USD","LU1496350502.SGD","LU1814569148.SGD","LU1951200564.SGD","LU0310800965.SGD","LU1670628061.USD","LU1035775433.USD","LU0426417589.USD","LU2756315664.SGD","LU0310799852.SGD","LU0312595415.SGD","LU1720051017.SGD","LU0323591593.USD","BK4532","LU0353189680.USD","LU0477156797.USD"],"gpt_icon":1},{"id":"2517449685","title":"Insider Trading Shakes Up Pacific Biosciences, Nutanix, Coupang, CSX, and Williams Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2517449685","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517449685?lang=en_us&edition=fundamental","pubTime":"2025-03-08 21:03","pubTimestamp":1741439020,"startTime":"0","endTime":"0","summary":"Insiders have been trading these 5 stocks: (($PACB)), (($NTNX)), (($CPNG)), (($CSX)) and (($WMB)). Here is a breakdown of their recent trades and t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/uncategorized/insider-trading-shakes-up-pacific-biosciences-nutanix-coupang-csx-and-williams-co?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/uncategorized/insider-trading-shakes-up-pacific-biosciences-nutanix-coupang-csx-and-williams-co?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BBT3K403.USD","LU1242518857.USD","LU0266512127.USD","BK4585","LU0208291251.USD","CPNG","LU0070302665.USD","IE00B29SXL02.USD","IE00BLSP4452.SGD","LU0320765489.SGD","LU0345781412.USD","CSX","LU2237443382.USD","LU0300736062.USD","LU1621767737.EUR","LU1242518931.SGD","IE00B3S45H60.SGD","IE00BD4GTW91.USD","BK4122","BK4220","LU2237443622.USD","LU0345780950.USD","BK4520","LU0788109394.HKD","LU0456854461.SGD","LU2384288077.EUR","IE00B775SV38.USD","LU0300736492.USD","IE00BD4GTT62.SGD","IE00BN8TJ469.HKD","WMB","BK4144","BK4588","LU2237443978.SGD","LU0630314457.HKD","LU1621768115.EUR","LU2237443549.SGD","LU2346227817.USD","LU1621768206.USD","BK4566","LU1074936037.SGD","LU0368265418.SGD","LU1621767810.EUR","BK4548","LU0979878070.USD","BK4532","BK4016","LU0122376428.USD","IE00BLSP4239.USD","IE00BD4GTV84.USD"],"gpt_icon":0},{"id":"2517445092","title":"Why The 49% Return On Capital At National Beverage (NASDAQ:FIZZ) Should Have Your Attention","url":"https://stock-news.laohu8.com/highlight/detail?id=2517445092","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517445092?lang=en_us&edition=fundamental","pubTime":"2025-03-08 20:00","pubTimestamp":1741435215,"startTime":"0","endTime":"0","summary":"If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a business will show two trends; firstly a growing return on capital employed  and secondly, an increasing amount of capital employed. This shows us that it's a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. Speaking of which, we noticed some great changes in National Beverage's  returns on capital, so let's have a look.For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. The formula for this calculation on National Beverage is:. Return on Capital Employed = Earnings Before Interest and Tax  ÷ . Therefore, National Beverage has an ROCE of 49%. In absolute terms that's a great return and it's even better than the Beverage industry average of 17%.Above you can see how the current ROCE for National Beverage compares t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-49-return-capital-national-120015162.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MNQmain","BK4112","IE00BKPKM429.USD","NVIW.SI","PSQ","LU2210150020.SGD","QID",".IXIC","EBIT","BK4585","IE00BGHQF748.EUR","NDAQ","IE00B3QW5Z07.USD","NQmain","IE00B64PRP62.GBP","USAW.SI","TSYW.SI","LU2095319765.USD","FIZZ","BK4588","BK4532","LU2210149790.SGD","BK4177","USJW.SI","TQQQ","QLD","SQQQ"],"gpt_icon":1},{"id":"2517445925","title":"An Intel deal now seems less likely. These clues may hold the key to its future.","url":"https://stock-news.laohu8.com/highlight/detail?id=2517445925","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517445925?lang=en_us&edition=fundamental","pubTime":"2025-03-08 20:00","pubTimestamp":1741435200,"startTime":"0","endTime":"0","summary":"Investors appear to be now be discounting recent M&A speculation that Intel will split in two. Intel Corp. investors appear to now be discounting recent speculation that the chip giant could be split in two as part of any sort of big merger deal.After Broadcom Inc.  Chief Executive Hock Tan told analysts late Thursday on the company's earnings call that he was \"too busy\" to pursue any mergers and acquisitions, that put a further dent in hopes that Intel would find a buyer for its design business.Intel's stock  reflects how investors already had soured on the company's merger prospects even before Tan's comments. The stock fell just fractionally in Friday's action, but it's down about 25% from this year's peak close of $27.39 hit on Feb. 18.However, not many people in Silicon Valley believed that a partnership between Intel and longtime rival TSMC would have been a good thing. \"Intel always had a","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348723411.USD","LU1244550577.SGD","LU0127658192.USD","LU2106854487.HKD","IE00BGHQF631.EUR","IE00BKVL7J92.USD","LU1211504680.USD","LU1548497426.USD","BK4579","BAM","TSM","IE00BQXX3C00.GBP","AVGO","INTC","LU1868837565.USD","LU0957791311.USD","LU1366192091.USD","LU0942090050.USD","LU0345770308.USD","IE00BZ9MQY76.HKD","LU0323591593.USD","LU2272731600.USD","03145","IE00BMCWC346.EUR","LU2028103732.USD","IE00BD6J9T35.USD","SG9999015945.SGD","IE00B19Z9Z06.USD","SGXZ99366536.SGD","IE00BVYPNQ40.USD","IE00BBT3K403.USD","BK4581","LU0264606111.USD","LU0320765059.SGD","LU1153585028.USD","LU0738911758.USD","LU1037948897.HKD","LU0889565833.HKD","LU0320765646.SGD","LU0949170772.SGD","LU0957808578.USD","LU1267930730.SGD","BN","LU0795875169.SGD","LU0787776722.HKD","LU1267930813.SGD","IE00BHPRN162.USD","SG9999011175.SGD","LU0868494708.USD","BK4532"],"gpt_icon":1},{"id":"2517244592","title":"Is Barrick Gold Corporation (GOLD) the Best Cash-Rich Undervalued Stock to Invest In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2517244592","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517244592?lang=en_us&edition=fundamental","pubTime":"2025-03-08 19:12","pubTimestamp":1741432376,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Cash-Rich Undervalued Stocks To Invest In.In this article, we are going to take a look at where Barrick Gold Corporation  stands against the other cash-rich undervalued stocks.For this article, we used the Finviz stock screener to identify cash-rich undervalued stocks. We applied a filter to select companies with P/E ratios under 15. Additionally, we used a current ratio  filter of over 2 to identify stocks with strong current assets. CR is a company’s current assets divided by its current liabilities. If the CR is over 1, it means the company has more assets than liabilities, usually because of high cash reserves, receivables, or inventory. After filtering, we manually searched for companies with TTM operating cash flow exceeding $2 bi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/barrick-gold-corporation-gold-best-111256160.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0345781412.USD","LU1023059493.AUD","CR","BK4585","LU1223082196.USD","LU0345770993.USD","LU0075056555.USD","LU0345770308.USD","LU0724618789.USD","LU0498741114.HKD","LU0368265764.SGD","LU0496367417.USD","LU0345780950.USD","BK4161","LU0055631609.USD","BK4588","LU0330918003.SGD","LU0788108826.HKD","SG9999001143.SGD","LU0345780281.USD","LU0345780521.USD","LU0630314457.HKD","BK4570","GOLD","BK4017","LU0498741890.SGD","LU1223083913.SGD","BK4532"],"gpt_icon":0},{"id":"2517830446","title":"This Customer Trend Helped Save Walmart's Quarter, but Does It Spell Trouble for the Year Ahead?","url":"https://stock-news.laohu8.com/highlight/detail?id=2517830446","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517830446?lang=en_us&edition=fundamental","pubTime":"2025-03-08 19:09","pubTimestamp":1741432140,"startTime":"0","endTime":"0","summary":"Walmart ended fiscal 2025 on a strong note, with same-store sales up 4.6% in the fourth quarter.The company noted that upper-income households were an important driver of its performance.Management's target demographic is lower down the socioeconomic spectrum.Walmart  is one of the largest and most powerful retailers in the world. It is performing quite well right now, with the company's fiscal fourth quarter 2025 same-store sales ticking up 4.6%.There's a wrinkle in this number, however, because it is being supported by customers who don't normally shop at Walmart. Here's why that's a problem.What does Walmart do?","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/03/08/this-customer-trend-helped-save-walmarts-quarter-b/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU1814569148.SGD","IE0034235188.USD","BK4504","LU1116320901.HKD","LU2505996509.AUD","LU1116320737.USD","BK4597","LU2264538146.SGD","BK4596","BK4155","BK4533","BK4581","LU0314104364.USD","LU0640476718.USD","LU2361044865.SGD","LU2125154935.USD","LU1035773651.USD","LU2505996681.GBP","LU2430703095.HKD","LU1280957306.USD","BK4550","LU2471134523.USD","LU2471134879.HKD","BK4585","LU0211327993.USD","LU2461242641.AUD","WMT","LU2750360641.GBP","LU0256863811.USD","BK4534","LU1988902786.USD","LU2430703251.USD","LU2430703178.SGD","LU1066051498.USD","LU0256863902.USD","LU0310799852.SGD","LU0417517546.SGD","LU0175139822.USD","BK4532","LU0265550946.USD","LU1430594728.SGD","LU2361044949.HKD","LU2471134796.USD","LU0265550359.USD","LU0149725797.USD","LU2592432038.USD","LU0211328371.USD","LU1064131342.USD","LU2750360997.AUD","LU1366192091.USD"],"gpt_icon":1},{"id":"2517344313","title":"Is Tenaris S.A. (TS) the Best Cash-Rich Undervalued Stock to Invest In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2517344313","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517344313?lang=en_us&edition=fundamental","pubTime":"2025-03-08 19:07","pubTimestamp":1741432075,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Cash-Rich Undervalued Stocks To Invest In.In this article, we are going to take a look at where Tenaris S.A.  stands against the other cash-rich undervalued stocks.For this article, we used the Finviz stock screener to identify cash-rich undervalued stocks. We applied a filter to select companies with P/E ratios under 15. Additionally, we used a current ratio  filter of over 2 to identify stocks with strong current assets. CR is a company’s current assets divided by its current liabilities. If the CR is over 1, it means the company has more assets than liabilities, usually because of high cash reserves, receivables, or inventory. After filtering, we manually searched for companies with TTM operating cash flow exceeding $2 billion as of De","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tenaris-ts-best-cash-rich-110755930.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TNRSF","BK4179","BK4532","TS","IE00B1B80R65.USD","CR","BK4161"],"gpt_icon":0}],"pageSize":16,"totalPage":111,"pageCount":25,"totalSize":1770}]}}